Roger Lias, Ph.D.

Chief Commercial Officer

Roger Lias joined Vibalogics as Chief Commercial Officer in 2021 to lead the global oversight of Vibalogics’ business development, sales, and program management divisions. Roger holds responsibility for harmonizing the approach for all customer interactions worldwide at both the rapidly growing business in Boxborough, Massachusetts and Cuxhaven, Germany facilities. Roger has over 25 years of experience in the biologics CDMO arena. Before joining Vibalogics, Roger held roles as Chief Executive Officer at Stelis Biopharma, and Avid Bioservices (NASDAQ: CDMO), where he was responsible for the successful transition to dedicated CDMO models. Prior to these roles, he held senior commercial roles at Diosynth and Lonza before becoming a member of the founding management teams at KBI Biopharma, Cytovance Biologics and Eden Biodesign. Roger holds a Ph.D. in Biochemistry from the University of Cambridge and holds a Bachelor of Science from the University of Southampton.